Papers
5
Total Citations
179
H-Index
3
About
Bas A. Uijterwijk is a leading researcher in hepatopancreatobiliary (HPB) surgery, with a primary focus on advancing minimally invasive techniques for complex pancreatic and liver cancers. His major contributions center on establishing evidence-based guidelines and generating high-quality comparative data to define the role of laparoscopic and robotic surgery. Notably, he is the lead author of the landmark "Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS)" (2023, 117 citations), which provides the first comprehensive, consensus-driven framework for safe implementation of these procedures. Uijterwijk has also conducted pivotal meta-analyses, including an individual patient data meta-analysis of randomized trials comparing minimally invasive versus open pancreatoduodenectomy for pancreatic cancer (2023, 30 citations). His work extends to long-term oncological outcomes, demonstrating the safety and efficacy of minimally invasive approaches for distal cholangiocarcinoma and ampullary adenocarcinoma through large, propensity score-matched international multicenter cohort studies. With a rapidly growing citation impact, Uijterwijk is shaping the future of surgical oncology by rigorously evaluating how innovation can improve patient outcomes without compromising oncologic principles.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5